Healthy
Showing NaN - NaN of 252
Healthy Trial in Seoul (DA-5215 Tab, DA-5215-R Tab)
Not yet recruiting
- Healthy
- DA-5215 Tab
- DA-5215-R Tab
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
May 11, 2022
Healthy Trial in Seoul (IN-C005 X mg, IN-A001 Y mg, IN-C005 Y mg)
Completed
- Healthy
- IN-C005 X mg
- +3 more
-
Seoul, Jongro Gu, Korea, Republic of
- +1 more
May 10, 2022
Healthy Trial in Seoul (Tacrolimus, IN-A001(Tegoprazan), IN-A001(Tegoprazan) + Tacrolimus)
Not yet recruiting
- Healthy
- Tacrolimus
- +2 more
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 25, 2022
Healthy Trial in Seoul (CG-745 IV Solution, CG-750 125mg capsule, PO Placebo)
Completed
- Healthy
- CG-745 IV Solution
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 19, 2022
Healthy Trial in Seoul (SJP002, Placebo)
Completed
- Healthy
- SJP002
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 7, 2022
Healthy Trial in Seoul (SA001 60mg or Placebo, SA001 120mg or Placebo, SA001 180mg or Placebo)
Completed
- Healthy
- SA001 60mg or Placebo
- +4 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 20, 2022
Colorectal Cancer, Colon Polyp, Healthy Trial in Korea, Republic of (Earlytect Colon Cancer)
Active, not recruiting
- Colorectal Cancer
- +2 more
- Earlytect Colon Cancer
-
Busan, Korea, Republic of
- +7 more
Feb 27, 2022
Healthy Trial in Seoul (Cilostazol, Probucol)
Completed
- Healthy
-
Seoul, Korea, Republic ofClinical Trial Center, Seoul National University Hospital
Feb 17, 2022
Healthy Trial in Seoul (CTO0101, Placebo (vehicle))
Recruiting
- Healthy
- CTO0101
- Placebo (vehicle)
-
Seoul, Korea, Republic ofTaejoon Pharmaceutical Co., Ltd.
Feb 21, 2022
Healthy Trial in Seoul (YH4808 NF 100, YH4808 OF 200, YH4808 NF 200)
Completed
- Healthy
- YH4808 NF 100
- +3 more
-
Seoul, Korea, Republic ofYonsei Medical Center Severance Hospital Clinical Trials Center
Dec 26, 2021
Healthy Trial in Korea, Republic of (CT-P17, US-licensed Humira, EU-approved Humira)
Completed
- Healthy
- CT-P17
- +2 more
-
Cheongju-si, Chungcheongbuk-do, Korea, Republic of
- +8 more
Nov 17, 2021
Healthy Trial in Seoul (NXC736, Placebo)
Recruiting
- Healthy
- NXC736
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 12, 2021
Healthy Trial in Seoul (IN-A002(IN-115314) capsule)
Recruiting
- Healthy
- IN-A002(IN-115314) capsule
-
Seoul, Korea, Republic ofSeoul National University Hospital, Dept. of Clinical Pharmacolo
Aug 19, 2021
Healthy Trial in Seoul (Normal saline, DWJ1521, DWP14012 Tablet)
Recruiting
- Healthy
- Normal saline
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jun 8, 2021
Healthy Trial in Seoul (IN-A012, Akynzeo 300Mg-0.5Mg Capsule)
Completed
- Healthy
- IN-A012
- Akynzeo 300Mg-0.5Mg Capsule
-
Seoul, Korea, Republic ofCatholic Univ. of Seoul St. Mary's Hospital
May 28, 2021
Healthy Trial in Seoul (hzVSF-v13, Placebo)
Completed
- Healthy
- hzVSF-v13
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Apr 4, 2021
Healthy Trial in Seoul (Aricept 5mg Tablet, Aricept 10mg Tablet, DA-5207 150mg)
Active, not recruiting
- Healthy
- Aricept 5mg Tablet
- +3 more
-
Seoul, Korea, Republic ofSeverance Hospital Clinical Trial Center
Apr 13, 2021
Healthy Trial in Seoul (DA-5207, Donepezil Hydrochloride)
Completed
- Healthy
- DA-5207
- Donepezil Hydrochloride
-
Seoul, Korea, Republic ofClinical Trials Center, Severance Hospital
Apr 13, 2021
Healthy Trial in Seoul (LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose)
Completed
- Healthy
- LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 10, 2021
Healthy Trial in Seoul (NVP-1805, NVP-1805-R1and NVP-1805-R2)
Completed
- Healthy
- NVP-1805
- NVP-1805-R1and NVP-1805-R2
-
Seoul, Nambusunhwan-ro, Korea, Republic ofH Plus Yangji Hospital
Mar 1, 2021
Healthy Trial in Seoul (DA-5209 60mg Tab, Lixiana 60mg Tab)
Completed
- Healthy
- DA-5209 60mg Tab
- Lixiana 60mg Tab
-
Seoul, Korea, Republic ofH Plus Yangji Hospital
Feb 8, 2021
Healthy Trial in Seoul (Eletriptan commercial tablet)
Completed
- Healthy
- Eletriptan commercial tablet
-
Seoul, Korea, Republic ofPfizer Investigational Site
Jan 26, 2021
Healthy Trial in Seoul (Tegoprazan 50 mg, EAPA115, RAPA115)
Completed
- Healthy
- Tegoprazan 50 mg
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital, Clinical Trial Center
Nov 29, 2020